- The Bavarian Nordic company holds the patent for the only monkeypox vaccine currently in existence, although it was originally created against smallpox.
- It is 80 percent effective in preventing serious illness and 100 percent effective in preventing the disease.
- Based on label directions, the vaccine is given in two doses four weeks apart.
Thanks to the sum of research and technology, it is possible to face the problems that affect the world in a better way. The best example is monkeypox vaccine that has become relevant recently and to learn more about the biological, its side effects have now been revealed. Does it really cause discomfort in those who receive it?
In the first instance, it should be noted that the Danish company Bavarian Nordic is the only one in the world that has the patent to manufacture this vaccine. Similarly, its initial central objective was to protect against smallpox, although some studies have shown that it also works against this variant of the disease.
For this reason, at the moment it is the only option that exists to deal with the current outbreak and maintains a presence in more than 20 countries in Europe, America and Oceania. Although there are also some drugs that are under development and could soon be approved to have more options available.
In this case, the Bavarian Nordic vaccine has the approval of the United States health authorities with the registration of JYNNEOS. While in Canada it goes by the name IMVAMUNE and also has the necessary approval.
Monkeypox Vaccine Side Effects
Now, from a study of the United States Food and Drug Administration (FDA) in which 7,800 people participated, it was obtained that the Monkeypox vaccine causes the following side effects:
- Pain.
- redness
- Swelling.
- Itch.
- Hardening at the injection site.
- Muscle pain.
- Headache.
- Fatigue.
The most important thing is that no cases of major incidents or nuisances have been reported so far. While the effects described correspond to those that develop immediately after receiving any other biological.
Application indications
Based on label directions, the vaccine is given in two doses four weeks apart. About its effectiveness, it is described as 80 percent to avoid serious conditions and 100 percent in the prevention of the disease.
While the manufacturing company mentions that the only contraindication is that it should not be applied to people with hypersensitivity to the active ingredient or to any of the excipients of the vaccine.
When did monkeypox appear?
The first cases in animals occurred during the 1950s. While the first human infection was recorded in 1970 in Zaire (the territory that is currently the Democratic Republic of the Congo).
For the above, actually it is not a new disease. The drawback is that for half a century it was endemic to Africa and it was in 2022 when the first cases were reported outside that continent.
Symptoms in patients
So far it has not been classified as a sexually transmitted disease and there is no specific treatment. This condition occurs with two clinical periods that generally disappear without complications between two and four weeks after the onset of symptoms.
The first phase that develops in the first five days is characterized by fever, intense headache, swollen glands, lower back pain, muscle aches and lack of desire to move or do any physical activity. The second phase is the appearance of small blisters, which begins on days one and three after the onset of fever. At that time, the different phases of the rash appear, which usually affects the face first and then spreads to the rest of the body.
The rash begins with macules and progresses asynchronously to vesicles, pustules, and crusts. It is a disease similar to chickenpox because both viruses are from the same family.